Xiamen
688278.SSXiamen Amoytop Biotech Co., Ltd. Price (688278.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
405,437,526
(0.3349)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Xiamen Amoytop Biotech Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
280,370,520.00
+0% |
323,081,460.00
+15% |
448,282,685.00
+39% |
729,666,393.00
+63% |
793,934,304.00
+9% |
1,132,227,709.00
+43% |
1,526,905,123.00
+35% |
2,100,322,880.00
+38% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 30,743,337.00 | 41,678,104.00 | 55,937,916.00 | 79,973,878.00 | 83,649,448.00 | 125,133,846.00 | 169,239,027.00 | 143,159,260.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
249,627,183.00
+0% |
281,403,356.00
+13% |
392,344,769.00
+39% |
649,692,515.00
+66% |
710,284,856.00
+9% |
1,007,093,863.00
+42% |
1,357,666,096.00
+35% |
1,957,163,620.00
+44% |
|||||||||||
| Gross Profit Ratio | (0.89%) | (0.87%) | (0.88%) | (0.89%) | (0.89%) | (0.89%) | (0.89%) | (0.93%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 8,932,629.00 | 18,902,636.00 | 40,606,651.00 | 53,405,572.00 | 76,675,423.00 | 81,507,131.00 | 149,836,321.00 | 221,359,820.00 | |||||||||||
| General and Administrative | 47,612,704.00 | 50,641,216.00 | 12,349,160.00 | 16,603,460.00 | 18,173,501.00 | 22,881,371.00 | 33,315,529.00 | 210,309,264.00 | |||||||||||
| Selling, General & Admin... | 200,709,213.00 | 254,006,702.00 | 278,863,170.00 | 436,286,962.00 | 446,849,649.00 | 620,436,986.00 | 736,463,996.00 | 1,057,809,665.00 | |||||||||||
| Selling & Marketing Exp... | 153,096,508.00 | 203,365,485.00 | 266,514,009.00 | 419,683,502.00 | 428,676,147.00 | 597,555,615.00 | 703,148,466.00 | 846,606,967.00 | |||||||||||
| Depreciation and Amortiz... | 18,244,600.00 | 26,617,400.00 | 37,952,093.00 | 37,928,311.00 | 38,804,877.00 | 44,327,511.00 | 50,375,640.00 | 58,693,815.00 | |||||||||||
| Other Expenses | -2,095,303.36 | -8,684,365.04 | -25,931,360.64 | 33,168,889.00 | 33,129,971.00 | 65,407,699.00 | 73,241,794.00 | -1,482,469.00 | |||||||||||
| Total Operating Expenses | 210,938,370.00 | 263,001,850.00 | 350,538,463.00 | 522,861,425.00 | 556,655,044.00 | 767,351,818.00 | 959,542,112.00 | 1,276,443,140.00 | |||||||||||
| Cost and Exponses | 241,681,707.00 | 304,679,955.00 | 406,476,380.00 | 602,835,304.00 | 640,304,492.00 | 892,485,665.00 | 1,128,781,140.00 | 1,419,602,401.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
29,971,310.00
+0% |
10,046,446.00
-66% |
34,717,957.00
+246% |
116,067,448.00
+234% |
158,140,352.00
+36% |
248,528,389.00
+57% |
406,924,314.00
+64% |
680,720,478.00
+67% |
|||||||||||
| Operating Income Ratio | (0.11%) | (0.03%) | (0.08%) | (0.16%) | (0.20%) | (0.22%) | (0.27%) | (0.32%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 161,488.00 | 302,600.00 | 264,418.00 | 450,127.00 | 2,782,639.00 | 2,851,651.00 | 4,569,057.00 | 6,627,012.00 | |||||||||||
| Interest Expenses | 4,859,056.00 | 4,078,940.00 | 7,224,468.00 | 6,300,467.00 | 2,462,430.00 | 1,074,491.00 | 620,728.00 | 784,068.00 | |||||||||||
| Total Other Income/Exp... | 2,893,359.00 | -2,377,134.00 | -20,443,149.00 | -25,054,744.00 | -19,073,140.00 | -33,242,398.00 | -50,998,470.00 | -40,065,990.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 56,504,039.00 | 40,737,838.00 | 68,124,850.00 | 135,090,289.00 | 179,697,909.00 | 260,904,163.00 | 404,621,310.00 | 699,854,476.00 | |||||||||||
| EBITDA ratio | (0.21%) | (0.12%) | (0.13%) | (0.19%) | (0.22%) | (0.23%) | (0.26%) | (0.33%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 32,864,669.00 | 7,669,312.00 | 14,274,808.00 | 91,012,704.00 | 139,067,212.00 | 215,285,991.00 | 355,925,844.00 | 640,654,488.00 | |||||||||||
| Income Before Tax Ratio | (0.12%) | (0.02%) | (0.03%) | (0.12%) | (0.18%) | (0.19%) | (0.23%) | (0.31%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 3,550,589.00 | 2,500,709.00 | -1,728,127.23 | 26,718,763.00 | 22,497,631.00 | 34,085,031.00 | 68,905,923.00 | 85,205,076.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 29,314,080.00
+0% |
5,168,602.00
-82% |
16,002,935.00
+210% |
64,293,940.00
+302% |
116,569,580.00
+81% |
181,200,959.00
+55% |
287,019,921.00
+58% |
555,449,411.00
+94% |
|||||||||||
| Net Income Ratio | (0.10%) | (0.02%) | (0.04%) | (0.09%) | (0.15%) | (0.16%) | (0.19%) | (0.26%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.09 | 0.01 | 0.04 | 0.16 | 0.29 | 0.45 | 0.71 | 1.37 | |||||||||||
| Diluted EPS | 0.09 | 0.01 | 0.04 | 0.16 | 0.29 | 0.45 | 0.71 | 1.37 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 325,712,003.00 | 516,860,299.00 | 400,073,383.00 | 406,800,000.00 | 406,800,000.00 | 406,800,000.00 | 406,800,000.00 | 405,437,526.00 | |||||||||||
| Diluted Share Outstanding | 325,712,003.00 | 516,860,299.00 | 400,073,383.00 | 406,800,000.00 | 406,800,000.00 | 406,800,000.00 | 406,800,000.00 | 405,437,526.00 | |||||||||||